Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective

Bone Marrow Transplant. 2018 Sep;53(9):1210-1213. doi: 10.1038/s41409-018-0178-5. Epub 2018 Apr 20.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Female
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Immunoglobulin Light-chain Amyloidosis / therapy*
  • Male
  • Melphalan / therapeutic use*
  • Middle Aged
  • Propylene Glycol
  • Retrospective Studies
  • Transplantation Conditioning / methods*
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Propylene Glycol
  • Melphalan